Extending the Boundaries of Cancer Care

    Patients who come to NewYork-Presbyterian/Weill Cornell Medical Center benefit from a team of nationally and internationally renowned cancer specialists, several of whom were recruited in the last two years, helping to take Weill Cornell to the next level in medical education, research, and patient care.

    Distinguished Faculty. Vibrant Translational Research. Superior Patient Care.

    Multidisciplinary Medical and Surgical Care

    Patients who receive cancer care at NewYork-Presbyterian/Weill Cornell have access to the vast array of resources of one of the most prominent academic medical centers in the world. Healthcare providers in every specialty – from cardiology, critical care, and endocrinology to neurology, neurosurgery, and pulmonology – are available to treat patients who have health issues beyond their cancer. Many of our patients were already being cared for at NewYork-Presbyterian/Weill Cornell before their diagnosis, enabling our physicians to treat them sooner, coordinate all of their healthcare needs, and manage the care process seamlessly and effectively.

    Latest Technological Advances

    NewYork-Presbyterian/Weill Cornell is accelerating the field of cell therapy and is a certified treatment center for CAR T-cell therapy for adults with recurrent or persistent diffuse large B-cell lymphoma (DLBCL), a common type of non-Hodgkin lymphoma. The expertise and skill of our CAR T-cell treatment teams, coupled with other specialists from all areas of medicine in one medical center, make NewYork-Presbyterian the ideal place to receive this potentially lifesaving treatment.

    Clinical Trials and Specialty Care

    All patients receiving cancer care at NewYork-Presbyterian/Weill Cornell may have access to clinical trials of promising new and innovative therapies, which often offer the only hope for those who are not responding to standard treatments. We have especially strong clinical research programs in upper digestive cancers, prostate cancer, and lung cancer. Through our translational research efforts, our oncologists create individualized treatment plans for patients based on the latest technological and scientific advances, collaborating with investigators to ensure that their medical discoveries are translated into effective, leading-edge therapies. Specialized programs include those for blood cancers, non-malignant hematology and vascular diseases, and bone marrow and stem cell transplantation.

    Magnet Designation: Demonstrating High Standards of Excellence in Patient Care

    In May 2019, NewYork-Presbyterian/Weill Cornell received national recognition for excellence in nursing from the American Nurses Credentialing Center’s (ANCC) Magnet Recognition Program®, the highest and most prestigious distinction that a healthcare organization can earn for nursing excellence and innovation. The credential – considered the gold standard for nursing – comprises a select group of approximately 9% of hospitals in the United States. Hospitals that achieve Magnet designation provide exemplary care across all disciplines, ensuring that our patients with cancer receive the highest quality care available.